Navigation Links
GlassesUSA.com and Cardinal Health in Strategic Partnership
Date:3/11/2010

Joint venture seeks to market affordable and stylish prescription eyeglasses

New Jersey (PRWEB) March 11, 2010 -- GlassesUSA.com and Cardinal Health, Inc. launched a partnership recently aimed at promoting an affordable and practical option in vision care. The partnership, in which Cardinal.com will promote GlassesUSA’s products and service for prescription eyeglasses and sunglasses at severely discounted prices is geared towards making the purchase of quality eyeglasses less expensive.

GlassesUSA.com, a New Jersey-based company, specializes in selling high-quality prescription glasses online at affordable prices with worldwide shipping options. GlassesUSA provides affordable eyewear to millions of people worldwide who cannot afford the high-price of glasses offered at many offline retail locations.Many of the eyeglasses sold at GlassesUSA.com are priced at 75% lower than the cost of traditional eyewear.

Cardinal Health, Inc. is an Ohio-based Fortune 18 company that "improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals and ambulatory care sites focus on patient care while reducing costs, improving efficiency and quality, and increasing profitability."

Jay Englemayer, the Vice President of Business Development at GlassesUSA, states that "Cardinal Health is a perfect partner for GlassesUSA as our overall missions are symbiotic. Affordable health care - including vision care for everyone.This alliance will help bring the reality
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... a way to sensitise cancer cells to chemotherapy - ... published today in Cell Reports , could pave ... cells that have become resistant to treatment. , The ... mechanisms behind resistance to chemotherapy drugs like Paclitaxel, often ... Andrew Gilmore, who led the research team at The ...
(Date:4/24/2014)... with the negative and stressful outcomes for parents who ... a life-limiting illness, says a recent study led by ... the challenges are numerous and life-changing and stress levels ... the Waterloo-led research reported positive outcomes as well, a ... the most recent issue of the American Journal ...
(Date:4/24/2014)... managing patients before, during and after colorectal surgery cut ... according to researchers who led a study of the ... enhanced recovery, is easier on patients before surgery, doing ... are typically prescribed. After surgery, patients are encouraged to ... to faster recoveries. , Among findings published in the ...
(Date:4/24/2014)... to be boring and irrelevant, could offer an alternative ... Researcher Dr Milena Furtado, and her team from the ... the heart cell fibroblast is a close relative to ... heart. , In research published today in Circulation ... are unique cells due to their genetic program, and ...
(Date:4/24/2014)... Depression affects more than one out of three ... study released in The Lancet Respiratory Medicine ... symptoms physically rather than mentally. , It is ... mental health and functional outcomes of critical care ... assistant professor of Medicine, and it highlights a ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Boring cells could hold the key to heart disease 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3
... March 9 (HealthDay News) -- A preliminary study reports that people ... drug just three times a week without major ill effects. ... research, and it,s not clear how much the drug would cost ... aside, the study raises the possibility that people with type 2 ...
... Boston, MA A team of researchers at Brigham ... out of every twelve adult smokers have abnormal lung ... of interstitial lung disease which is associated with substantial ... positively associated with smoking, these lung densities were inversely ...
... Nottingham could provide hope for any allergy sufferers who ... their household pet. The team of immunologists led ... of Molecular Medical Sciences, and funded by the charity ... a key role in triggering allergic responses to cat ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, March ... former-smokers develop lung conditions that reduce lung capacity, but leave ... pulmonary disease (COPD), new research shows. In fact, the ... New England Journal of Medicine found that these ...
... sheds light--both literally and figuratively--on the intricate brain ... Stanford University recently used light to activate mouse ... or decrease anxiety-related behaviors. Pinpointing the origin of ... disorders, the most common class of psychiatric disease. ...
... Satellites have been busy this week covering severe weather across ... captured an image of the huge stretch of clouds associated ... its slow march eastward. Earlier this week, NASA,s Tropical Rainfall ... tornadoes over Louisiana. Today the eastern third of ...
Cached Medicine News:Health News:New Drug May Trim Insulin Injections to Just 3 a Week 2Health News:Researchers find smoking may increase risk for lung disease 2Health News:Nottingham scientists identify trigger in cat allergy 2Health News:Lesser Known Lung Diseases Can Strike Smokers, Ex-Smokers 2Health News:Researchers selectively control anxiety pathways in the brain 2Health News:NASA and other satellites keeping busy with this week's severe weather 2Health News:NASA and other satellites keeping busy with this week's severe weather 3Health News:NASA and other satellites keeping busy with this week's severe weather 4Health News:NASA and other satellites keeping busy with this week's severe weather 5
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... NewCardio, Inc. (OTC Bulletin Board: NWCI ... Dr. Samuel George, NewCardio,s Senior Medical Advisor, will present ... dataset, conducted independently by the Cardiac Safety Research Consortium ... on December 9, 2010, at the headquarters of the ...
... The addition of Cimzia® (certolizumab pegol; CZP) to ... response, improved function and reduced disease activity in ... patients reflecting those seen in daily clinical practice ... clinical trial data were presented during the American ...
Cached Medicine Technology:NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 2NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 3NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 2New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 3New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 5New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 6New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 7New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 8New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 9New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 10
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: